ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm Receives $7.4m R&D Tax Incentive Refund
Published: 18/11/22, 02:06pm (AEST)•1 pages